Remarkably, our secretory adenomyosis organoids showed significant TGF-β2 and SMAD3 upregulation compared with controls, confirming successful secretory-phase differentiation and accurate reproduction of specific disease traits. This evidence concerns the gene SMAD3 and adenomyosis.